University of Pittsburgh reports best gene delivery to date of protein missing in Duchenne Muscular Dystrophy
Using sophisticated techniques, University of Pittsburgh scientists have engineered perhaps the best gene therapy to date for the prevalent life-threatening disease, Duchenne muscular dystrophy. The research, conducted in animals and reported in the Nov. 28 issue of the Proceedings of the National Academy of Sciences, are remarkable on several fronts.
Parent Project, NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
University of Pittsburgh Medical Center
Message posted by: Wouter Kalle